Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Post a job

Symposium

[Free Online Symposium] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery


Speakers: Abraham Heifets (Atomwise); Tom Miller (Entos AI); Fio Ruggiu (Insitro); Wayne Tang & Sathesh Bhat (Schrodinger); Alex Zhavoronkov (Insilico); Vijay Shahani (Cyclica); Brandon Allgood (Valo Health)
Organizers: Kevin McLure (Ermaris Bio) and Leping Li (Haihe Biopharma)
Date: 2021-11-17- 11/18/2021
Time: 8:30-13:00 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor: (1)Applied Biomath;(Major Sponsorship - Day 1 still open)
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-11-15  (it will close sooner if the seating cap is reached)

About the Topic

Day 1: November 17

PST

EST

Topic

Presenter

8:30am - 8:45am

11:30am- 11:45am

Welcome Remarks

Kevin McLure (Ermaris Bio)

8:45am - 9:30am

11:45am- 12:30pm

Results from the world’s largest distributed prospective application of machine learning to small molecule hit discovery

Abraham Heifets (Atomwise)

9:30am-10:15am

12:30pm - 1:15pm

Physics-informed deep learning to accelerate molecular simulation and drug discovery

Tom Miller (Entos AI)

10:15am- 10:25am

1:15pm - 1:25pm

Break

 

10:25am- 10:35am

1:25pm - 1:35pm

Major Sponsor Presentation

 Applied BioMath

10:35am- 11:20am

1:35pm - 2:20pm

Leveraging DNA-encoded library data with machine learning to identify diverse, novel molecular binders to challenging targets

Fio Ruggiu (Insitro)

11:20am- 12:05pm

2:20pm - 3:05pm

Applying Schrodinger computational modeling technology to accelerate discovery of novel inhibitors of D-amino acid oxidase

Wayne Tang & Sathesh Bhat (Schrodinger)

12:05pm-12:20pm

3:05pm - 3:20pm

PANEL DISCUSSION

All speakers

Day 2: November 18

PST

EST

Topic

Presenter

8:30am - 8:45am

11:30am- 11:45am

Welcome Remarks

Kevin McLure (Ermaris Bio)

8:45am - 9:20am

11:45am- 12:20pm

Target Discovery PandaOmics: from hypothesis generation to preclinical candidate nomination

Alex Zhavoronkov (Insilico)

9:20am - 10:05am

12:20pm - 1:05pm

Filling in the gaps: exploring polypharmacology with MatchMaker

Vijay Shahani (Cyclica)

10:05am- 10:15am

1:05pm-1:15pm

Break

-

10:15am-11:00am

1:15pm-2:00pm

Decreasing the risk of immunotoxicity for cancer immunotherapies

Giovanni Mazzocco (Ardigen)

11:00am -11:15am

2:00pm - 2:15pm

PANEL DISCUSSION

 All speakers


2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: Untangling What We Thought We Knew and Future Precision Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-08-14, [Free Online] Advances in Cancer Therapeutics
2024-09-10, [In-Person] Translational PK/PD and Human Dose Projections for Antibodies and Novel Therapeutic Modalities: Antibodies, ADCs, Covalent Inhibitors, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
┬ęPharmaceutical & BioScience Society, International; Last Modified: 5/29/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Simulations Plus Join us for MIDD+ San Francisco, a free event June 6-7. Hear scientific presentations from industry leaders, train with experts & connect with peers.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad